DPIIT recognised startup Government of India
Startup India
Crompton Pharma Private Limited - pharma in Panchkula, Haryana, India. Directors, charges & compliance details.
Revenue · FY 2025
₹56.15 Lakh
▲ 35% YoY
Net profit · FY 2025
₹33,211
Net margin 0.6%
EBITDA · FY 2025
₹5.29 Lakh
EBITDA margin 9.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹30 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Crompton Pharma Private Limited
Data last updated:
Crompton Pharma Private Limited is a private limited company based in Panchkula, Haryana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304HR2021PTC095873. Its GSTIN is 06AAJCC5735E1ZR (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Anurag Gupta (Managing Director) and Vaishali Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Second Floor SCO – 11 Sector – 11, Panchkula, Haryana, India – 134109.
As per the financials filed for FY 2025, the company reported a revenue of ₹56.15 Lakh, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹33,211 (net margin 0.6%) and EBITDA of ₹5.29 Lakh (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 117% over three years.
As per MCA filings, the company has open charges of ₹30 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
Crompton Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0003935). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cromptonpharma.com.
Company details
CIN U24304HR2021PTC095873
Registration Number 095873
Incorporation Date 26 June 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-HR-13-0003935
Recognitions & Rankings of Crompton Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-HR-13-0003935
Contact details
Crompton Pharma Private Limited's registered office is in Panchkula, Haryana.
- Registered AddressSecond Floor SCO – 11 Sector – 11, Panchkula, Haryana, India – 134109
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Crompton Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Crompton Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Crompton Pharma Private Limited, buy the company report.
Financials of Crompton Pharma Private Limited
FY 2025 filings availableCrompton Pharma Private Limited reported revenue of ₹56.15 Lakh (up 35% YoY) for FY 2025.
Revenue · FY 2025
₹56.15 Lakh ▲ 35%
Net profit · FY 2025
₹33,211 margin 0.6%
EBITDA · FY 2025
₹5.29 Lakh margin 9.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 117%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 40%
Revenue has grown at a compounded annual rate (CAGR) of 117% over three years, including 35% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹5.29 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹33,211 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 9.4% | |||
| Net Profit Margin | 0.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Crompton Pharma Private Limited, buy the company report.
Board of directors of Crompton Pharma Private Limited
Crompton Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anurag Gupta | Managing Director | 26 Jun 2021 | 5 Years 4 Months | Current |
| Vaishali Agarwal Also directs: Viduksh Pharma Private Limited, A2a Mart Private Limited | Director | 26 Jun 2021 | 5 Years 4 Months | Current |
Peer comparison
Crompton Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nimaco Formulations (India) Private Limited | ₹56.37 Lakh (FY 2024) | -77.0% | Ahmedabad, Gujarat, India | |||
| Excel Waves Labs Private Limited | ₹56.16 Lakh (FY 2022) | -72.0% | New Delhi, Delhi, India | |||
| Crompton Pharma Private Limitedthis company | ₹56.15 Lakh (FY 2025) | ₹33,211 | 0.6% | 35.0% | Panchkula, Haryana, India | |
| Ruta Marketing Private Limited | ₹56.11 Lakh (FY 2023) | 77.0% | Pune, Maharashtra, India | |||
| M R Pharmaceutical Technologies Private Limited | ₹55.81 Lakh (FY 2024) | 85.0% | New Delhi, Delhi, India |
To see the full peer comparison of Crompton Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹30 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jun 2023 | 100729602 | Others | ₹30 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Crompton Pharma Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Civil suit | Filed against the company by Crompton Greaves Consumer Electricals Limited | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed against the company by M/S Park Pharmaceuticals | Disposed |
To see the full case history of Crompton Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Crompton Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Crompton Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAJCC5735E1ZR | Haryana | Active | 20 Jul 2021 |
To see the full GST registrations and return filing status of Crompton Pharma Private Limited, buy the company report.
Recent activity
Crompton Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Anurag Gupta was appointed as Managing Director on 26 Jun 2021.
AGM
Crompton Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Crompton Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 30.00 Lakh with Charge ID 100729602 was registered on 08 Jun 2023.
Appointed
Anurag Gupta was appointed as Managing Director.
Appointed
Vaishali Agarwal was appointed as Director.
Incorporation
26 Jun 2021
Crompton Pharma Private Limited was registered on 26 Jun 2021 with Roc Delhi & aged 5 years 4 months as per MCA records.
Frequently asked questions
Crompton Pharma is an active private limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 June 2021 (5+ years old) and is registered under CIN U24304HR2021PTC095873.
Crompton Pharma has 2 current directors:
- Anurag Gupta - Managing Director
- Vaishali Agarwal - Director
The latest financial statements of Crompton Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Crompton Pharma is 06AAJCC5735E1ZR, registered in Haryana.
The CIN (Corporate Identification Number) of Crompton Pharma is U24304HR2021PTC095873. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Crompton Pharma has 2 court cases on record: 2 filed against it. 1 is pending.
Crompton Pharma was incorporated on 26 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Crompton Pharma by revenue are Nimaco Formulations (India) Private Limited, Excel Waves Labs Private Limited, Ruta Marketing Private Limited, M R Pharmaceutical Technologies Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Anurag Gupta was appointed as Managing Director on 26 Jun 2021. Vaishali Agarwal was appointed as Director on 26 Jun 2021.
Yes, Crompton Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Crompton Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0003935).